ZS-9

AstraZeneca potassium drug finally approved, threatening Vifor
Yahoo/Reuters
Mon, 05/21/18 - 09:01 am
AstraZeneca
Lokelma
hyperkalemia
ZS-9
Vifor
Valtessa
FDA
When Will They Learn? 4 Huge Biotech Blowups
Motley Fool
Thu, 03/29/18 - 09:24 pm
biotech
AstraZeneca
ZS-9
drug manufacturing
Alexion
Synageva
Merck
Cubist Pharmaceuticals
AbbVie
Rova-T
Stemcentrx
FDA explains why it rejected AstraZeneca's ZS-9
BioPharma Dive
Fri, 04/21/17 - 11:27 am
FDA
AstraZeneca
ZS-9
FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
Fierce Pharma
Wed, 04/19/17 - 04:12 pm
FDA
AstraZeneca
ZS-9
ZS Pharma
hyperkalemia
FDA Rejects AstraZeneca’s Hyperkalemia Drug
Investopedia
Fri, 03/17/17 - 09:29 am
AstraZeneca
FDA
hyperkalemia
ZS-9
A Great Month For Relypsa
Seeking Alpha
Sat, 05/28/16 - 10:38 am
Relypsa
AstraZeneca
Veltassa
hyperkalemia
ZS-9
AstraZeneca Remains Committed To Development Of ZS-9 Despite Letter From FDA
Yahoo/Benzinga
Fri, 05/27/16 - 12:42 pm
AstraZeneca
FDA
ZS-9
hyperkalaemia
ZS Pharma
3 Big Battles Brewing in Biotech
Motley Fool
Sun, 04/10/16 - 01:50 pm
AstraZeneca
ZS-9
Relypsa
Veltassa
Synergy Pharmaceuticals
plecanatide
Linzess
Ironwood
Allergan
Incyte
Eli Lilly
baricitinib
AbbVie
Humira
Encouraging Results For Two New Drugs That Fight A Common And Dangerous Side Effect
Forbes
Fri, 11/21/14 - 03:10 pm
RAAS
ZS Pharma
hyperkalemia
ZS-9
Relypsa
ZS Pharma begins enrollment in phase 3 study of ZS-9 in Hyperkalemia patients
Pharmabiz
Sat, 06/28/14 - 11:49 am
hyperkalemia
ZS Pharma
ZS-9